Beam Therapeutics, Inc. (BEAM)
23.99
-0.38
(-1.56%)
USD |
NASDAQ |
Sep 11, 16:00
24.02
+0.03
(+0.13%)
After-Hours: 20:00
Beam Therapeutics Price to Book Value : 2.321 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.321 |
| September 10, 2026 | 2.358 |
| September 09, 2026 | 2.435 |
| September 08, 2026 | 2.596 |
| September 04, 2026 | 2.869 |
| September 03, 2026 | 2.85 |
| September 02, 2026 | 2.834 |
| September 01, 2026 | 2.807 |
| August 31, 2026 | 2.847 |
| August 28, 2026 | 2.836 |
| August 27, 2026 | 2.949 |
| August 26, 2026 | 2.921 |
| August 25, 2026 | 3.002 |
| August 24, 2026 | 2.741 |
| August 21, 2026 | 2.879 |
| August 20, 2026 | 2.746 |
| August 19, 2026 | 2.812 |
| August 18, 2026 | 2.570 |
| August 17, 2026 | 2.622 |
| August 14, 2026 | 2.588 |
| August 13, 2026 | 2.565 |
| August 12, 2026 | 2.584 |
| August 11, 2026 | 2.598 |
| August 10, 2026 | 2.639 |
| August 07, 2026 | 2.658 |
| Date | Value |
|---|---|
| August 06, 2026 | 2.636 |
| August 05, 2026 | 2.619 |
| August 04, 2026 | 2.743 |
| August 03, 2026 | 2.506 |
| July 31, 2026 | 2.469 |
| July 30, 2026 | 2.563 |
| July 29, 2026 | 2.517 |
| July 28, 2026 | 2.543 |
| July 27, 2026 | 2.425 |
| July 24, 2026 | 2.428 |
| July 23, 2026 | 2.506 |
| July 22, 2026 | 2.577 |
| July 21, 2026 | 2.64 |
| July 20, 2026 | 2.547 |
| July 17, 2026 | 2.663 |
| July 16, 2026 | 2.746 |
| July 15, 2026 | 2.984 |
| July 14, 2026 | 2.988 |
| July 13, 2026 | 2.999 |
| July 10, 2026 | 3.162 |
| July 09, 2026 | 3.465 |
| July 08, 2026 | 3.568 |
| July 07, 2026 | 3.668 |
| July 06, 2026 | 3.417 |
| July 02, 2026 | 3.366 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 17.89 |
| Prime Medicine, Inc. | 14.21 |
| Intellia Therapeutics, Inc. | 2.259 |
| Sarepta Therapeutics, Inc. | 1.414 |
| Revolution Medicines, Inc. | 16.75 |
Price to Book Value Related Metrics
| PS Ratio | 15.95 |
| Price | 23.99 |
| Earnings Yield | -3.58% |
| Market Cap | 2.477B |